SAM
KYMR icon

Smartleaf Asset Management’s Kymera Therapeutics KYMR Stock Holding History

Smartleaf Asset Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.5K Hold
608
– – ﹤0.01% 1370
2026
Q1 		$48.3K Buy
608
+73
+14% +$5.78K ﹤0.01% 1468
2025
Q4 		$41.8K Buy
535
+424
+382% +$28.6K ﹤0.01% 1641
2025
Q3 		$6.49K Buy
111
+55
+98% +$2.48K ﹤0.01% 2287
2025
Q2 		$2.47K Sell
56
-115
-67% -$3.96K ﹤0.01% 2271
2025
Q1 		$5.07K Buy
171
+40
+31% +$1.46K ﹤0.01% 2184
2024
Q4 		$5.15K Sell
131
-32
-20% -$1.45K ﹤0.01% 2238
2024
Q3 		$7.94K Sell
163
-41
-20% -$1.81K ﹤0.01% 1895
2024
Q2 		$6.16K Buy
204
+181
+787% +$6.27K ﹤0.01% 1694
2024
Q1 		$923 Buy
+23
New +$823 ﹤0.01% 1637

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Smartleaf Asset Management's KYMR Position: Q2 2026 in Review

Smartleaf Asset Management held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 608 shares worth $66.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1370.

Smartleaf Asset Management first reported a position in KYMR in Q1 2024 and has held it in 10 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Smartleaf Asset Management held 608 shares of Kymera Therapeutics worth $66.5K as of Q2 2026.
  • Smartleaf Asset Management left its Kymera Therapeutics share count unchanged in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1370 holding.
  • Smartleaf Asset Management first reported a position in Kymera Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.